Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England
Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England
The Development and Evaluation Committee (DEC) provides local guidance on the value of new and existing health care technologies, including drugs, devices, procedures and health care settings. The system is made up of two components: i) literature review and cost‐effectiveness estimation of the proposed and current technologies, and ii) consideration by the Development and Evaluation Committee which arbitrates, makes recommendations and disseminates results across the South and West region. Sixty‐three reviews have been undertaken to date, including, for example, beta interferon for multiple sclerosis, pulsed dye laser in the treatment of port‐wine stains, and paclitaxel in ovarian cancer. The outcomes of this service are guides to purchasing which are both carefully researched and scrutinized.
51-56
Best, Lesley
7c4a1fe5-21a1-4634-a1cc-0230322603d1
Stevens, Andrew
e4ad8d5c-5041-4eaf-be50-1baa36e3ed47
Colin-Jones, Duncan
53045e55-776a-40bd-b4d8-8067a42a677a
June 1997
Best, Lesley
7c4a1fe5-21a1-4634-a1cc-0230322603d1
Stevens, Andrew
e4ad8d5c-5041-4eaf-be50-1baa36e3ed47
Colin-Jones, Duncan
53045e55-776a-40bd-b4d8-8067a42a677a
Best, Lesley, Stevens, Andrew and Colin-Jones, Duncan
(1997)
Rapid and responsive health technology assessment: the development and evaluation process in the South and West region of England.
Journal of Clinical Effectiveness, 2 (2), .
(doi:10.1108/eb020865).
Abstract
The Development and Evaluation Committee (DEC) provides local guidance on the value of new and existing health care technologies, including drugs, devices, procedures and health care settings. The system is made up of two components: i) literature review and cost‐effectiveness estimation of the proposed and current technologies, and ii) consideration by the Development and Evaluation Committee which arbitrates, makes recommendations and disseminates results across the South and West region. Sixty‐three reviews have been undertaken to date, including, for example, beta interferon for multiple sclerosis, pulsed dye laser in the treatment of port‐wine stains, and paclitaxel in ovarian cancer. The outcomes of this service are guides to purchasing which are both carefully researched and scrutinized.
This record has no associated files available for download.
More information
Published date: June 1997
Identifiers
Local EPrints ID: 485572
URI: http://eprints.soton.ac.uk/id/eprint/485572
ISSN: 1361-5874
PURE UUID: 6acfba31-6492-477e-b369-d2086ebd3304
Catalogue record
Date deposited: 11 Dec 2023 17:35
Last modified: 18 Mar 2024 03:53
Export record
Altmetrics
Contributors
Author:
Andrew Stevens
Author:
Duncan Colin-Jones
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics